Kovelman Harry, the Chief Medical Officer of Myomo, Inc., has acquired 32,500 shares of the company's common stock. This acquisition was reported in a recent SEC filing dated October 15, 2026. The transaction is significant as it highlights Myomo's strategy to incentivize key personnel through stock options, which is a common practice in the industry.
Background
Myomo, Inc. is a company focused on the development of orthopedic, prosthetic, and surgical appliances and supplies. The company is incorporated in Delaware and operates from Boston, Massachusetts. Myomo trades under the ticker symbol MYO. Recent filings show that the company is actively managing its equity structure to align with its operational goals.
What the Filing Says
The SEC filing indicates that Kovelman acquired the shares on October 13, 2026, with the transaction categorized as an acquisition. Notably, the filing states, "Represents grant of restricted stock units (RSUs) under the Company's 2018 Stock Option and Incentive Plan. The RSUs vest in three equal annual installments beginning on June 9, 2027." Following this transaction, Kovelman now holds a total of 122,389 shares of Myomo.
Impact
This acquisition may affect Myomo's internal dynamics by reinforcing the commitment of its executive team, particularly in the competitive landscape of the orthopedic and surgical appliance industry. Stakeholders and employees may view this as a positive signal of the company's growth and stability.
What's Next
The filing does not say what happens next.